{"id":"dw51211","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Common Adverse Event 1"},{"rate":"1-5%","effect":"Common Adverse Event 2"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action of DW51211 is not well understood, but it is believed to work by interacting with the molecular target, leading to a specific therapeutic effect.","oneSentence":"DW51211 is a small molecule drug that targets the molecular target.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:10:24.130Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Indication 1"},{"name":"Indication 2"}]},"trialDetails":[{"nctId":"NCT07093697","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212","status":"COMPLETED","sponsor":"Daewon Pharmaceutical Co., Ltd.","startDate":"2024-03-28","conditions":"Acute Bronchitis","enrollment":273}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"DW51211","genericName":"DW51211","companyName":"Daewon Pharmaceutical Co., Ltd.","companyId":"daewon-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DW51211 is a small molecule drug that targets the molecular target. Used for Indication 1, Indication 2.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}